Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02382991
Other study ID # 20PT002-FR-01-0614
Secondary ID 2014-A00754-43
Status Completed
Phase N/A
First received
Last updated
Start date March 2015
Est. completion date November 2015

Study information

Verified date September 2019
Source Otto Bock France SNC
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Moderately active amputees may have lost their limb due to diabetes, vascular conditions, trauma, tumour or congenital causes. These amputees currently cannot benefit from having a computerised knee because of the performance criteria associated with being given one. However, these amputees have a very high risk of falling because they use a non microprocessor controlled knee joint (NMPK) and because their physical ability, associated disability and persistent contralateral leg weakness do not allow them to compensate for a balance deficit. These amputees restrict how much they move around and their participation because of their instability and elevated risk of falling.

The objective of the study is to evaluate the effect of the 3C60 knee, a microprocessor-controlled knee joint for external leg prosthesis, on the reduction in the risk of falling after three months in moderately active persons with leg amputation above knee or knee disarticulation.


Description:

The patient will be evaluated after one month of using his/her usual non micropressor controlled knee joint (NMPK). After fitting of the 3C60, the patient will undergo at least five rehabilitation sessions, adapted to his/her individual needs, so that he/she knows how to use the device and is ready to go along with the planned testing.

After the trial with the 3C60 knee, the patient will again be fitted with his/her non microprocessor controlled knee joint (NMPK) and will be required to undergo one rehabilitation session to regain his/her walking abilities.


Recruitment information / eligibility

Status Completed
Enrollment 35
Est. completion date November 2015
Est. primary completion date November 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Person with leg amputation above knee or knee disarticulation with stabilized residual limb

- Person who are currently fitted with a prosthesis using a non-microprocessor controlled prosthetic knee

- Person with a high risk of falling, which is defined as a TGUG test score of more than 19 seconds

- Person who moves around within buildings other than one's residence, such as moving around other people's homes, other private buildings, community and private or public buildings and enclosed areas, moving throughout all parts of buildings and enclosed areas, between floors, inside, outside and around buildings, both public and private

- Person who moves around outside the home and other buildings, such as walking and moving around close to or far from one's home and other buildings, without the use of transportation, public or private, such as walking for short or long distances around a town or village, walking or moving down streets in the neighbourhood, town, village or city; moving between cities and further distances, without using transportation

- Person with a daily walking distance greater than 300 m

Exclusion Criteria:

- Persons using underarm crutches or walkers

- Persons under 18 years of age

- Persons who weigh more than 125 kg

- Pregnant women

- Persons in an emergency situation

- Persons who cannot personally provide their consent

- Persons who are not available to follow the entire study protocol

Study Design


Related Conditions & MeSH terms

  • Amputation of Hip and Thigh, Level Unspecified

Intervention

Device:
3C60-NMPK
3 months with 3C60 - 10 days wash out - 1 month with NMPK
NMPK-3C60
1 month with NMPK - 3 months with 3C60

Locations

Country Name City State
Austria Sonderkrankenanstalt Zicksee Sankt Andrä am Zicksee
France CRMPR "Les Herbiers" Bois Guillaume
France Hôpital d'instruction des Armées Percy Clamart
France Centre Hospitalier de Cornouaille Concarneau Concarneau
France Centre de réadaptation de Coubert Coubert
France CHU de Grenoble Hôpital Sud Echirolles
France Clinique Chantecler Marseille
France Institut Régional de Médecine Physique et de Réadaptation Nancy
France Hôpital Léopold Belan Paris
France Institut National des Invalides Paris
France Pôle Saint-Hélier Rennes
France Hôpital privé de l'Est Lyonnais Saint Priest
France Centre l'Adapt Thionis Thionville
France Institut Robert Merle d'Aubigné Valenton
Germany Universitätsmedizin Göttingen Göttingen

Sponsors (1)

Lead Sponsor Collaborator
Otto Bock France SNC

Countries where clinical trial is conducted

Austria,  France,  Germany, 

References & Publications (15)

Burnfield JM, Eberly VJ, Gronely JK, Perry J, Yule WJ, Mulroy SJ. Impact of stance phase microprocessor-controlled knee prosthesis on ramp negotiation and community walking function in K2 level transfemoral amputees. Prosthet Orthot Int. 2012 Mar;36(1):95-104. doi: 10.1177/0309364611431611. Epub 2012 Jan 5. — View Citation

Demers L, Weiss-Lambrou R, Ska B. Development of the Quebec User Evaluation of Satisfaction with assistive Technology (QUEST). Assist Technol. 1996;8(1):3-13. — View Citation

Dite W, Connor HJ, Curtis HC. Clinical identification of multiple fall risk early after unilateral transtibial amputation. Arch Phys Med Rehabil. 2007 Jan;88(1):109-14. — View Citation

Franchignoni F, Orlandini D, Ferriero G, Moscato TA. Reliability, validity, and responsiveness of the locomotor capabilities index in adults with lower-limb amputation undergoing prosthetic training. Arch Phys Med Rehabil. 2004 May;85(5):743-8. — View Citation

Gauthier-Gagnon C, Grisé MC, Potvin D. Enabling factors related to prosthetic use by people with transtibial and transfemoral amputation. Arch Phys Med Rehabil. 1999 Jun;80(6):706-13. — View Citation

Gauthier-Gagnon C, Grisé MC. Prosthetic profile of the amputee questionnaire: validity and reliability. Arch Phys Med Rehabil. 1994 Dec;75(12):1309-14. — View Citation

Gauthier-Gagnon, C, grisé, MCL, Lepage Y. The Locomotor Capabilities Index : Content validity. J rehabil OutcomesMeas 2(4) : 40-46, 1998.

Gauthier-Gagnon, C, Grisé, MCL, Potvin, L. Predisposing factors related to prosthetic use by people with a transtibial and transfemoral amputation. J Prosthet Orthot 10: 99-109, 1998

Grisé MC, Gauthier-Gagnon C, Martineau GG. Prosthetic profile of people with lower extremity amputation: conception and design of a follow-up questionnaire. Arch Phys Med Rehabil. 1993 Aug;74(8):862-70. — View Citation

Leplège A, Mesbah M, Marquis P. [Preliminary analysis of the psychometric properties of the French version of an international questionnaire measuring the quality of life: the MOS SF-36 (version 1.1)]. Rev Epidemiol Sante Publique. 1995;43(4):371-9. French. — View Citation

Leplège, A. (2001). Introduction, enjeux, définitions. In J. Coste et A. Leplège (Eds.), Mesure de la santé perceptuelle et de la qualité de vie : méthodes et applications (pp 15-36). Paris : Editions Estem

Loiret I, Paysant J, Martinet N, André JM. [Evaluation of amputees]. Ann Readapt Med Phys. 2005 Jul;48(6):307-16. Epub 2005 Apr 15. Review. French. — View Citation

Schoppen T, Boonstra A, Groothoff JW, de Vries J, Göeken LN, Eisma WH. The Timed "up and go" test: reliability and validity in persons with unilateral lower limb amputation. Arch Phys Med Rehabil. 1999 Jul;80(7):825-8. — View Citation

Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473-83. — View Citation

Ware JE, Snow KK, Kosinski M, Gandek B (1993). Health survey : manual and interpretation guide. Boston, Massachussets : The Health Institute, New England Medical Center, 1993

* Note: There are 15 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Timed Get Up and Go (TGUG) This test consists of recording the amount of time needed for a person to stand up from a chair, walk 3 metres, make a half-turn and sit down again. The TGUG test score reflects a person's balance and as a consequence, the risk of falling. Measurement will be performed at 3 months with 3C60 and at 1 month with NMPK
Secondary Locomotor Capabilities Index (LCI-5) The Locomotor Capabilities Index (LCI-5) is a 14 item self-assessment questionnaire filled in by the patient that explores walking and ambulation. The LCI-5 is derived from the Prosthesis Profile of the Amputee Questionnaire (PPA). LCI-5 is sensitive to the use of walking aids or to the need of a third party. Ceiling effect is not expected with moderately active amputees. The global LCI-5 score is the addition of the 14 scores, noted between 0 and 4. The global score varies between 0 and 56, the highest being for persons with high locomotors capabilities. LCI-5 has two sub-scores: the basic score corresponds to 7 questions related to basic activities and the advanced score corresponds to 7 questions related to more advanced activities. The basic and advanced scores both range from 0-28. Higher scores correspond with a better outcome. Measurement will be performed at 3 months with 3C60 and at 1 month with NMPK
Secondary Use of Walking Aids The type of walking aids used with each device will be recorded. Measurement will be performed at 3 months with 3C60 and at 1 month with NMPK
Secondary QUEST 2.0 Satisfaction Questionnaire (QUEST 2.0-G: German Version / ESAT: French Version) It is a self-evaluation questionnaire of the user's satisfaction, translated in French (ESAT) and in German (QUEST 2.0-G Section 17.5). The QUEST 2.0 questionnaire contains 8 items that evaluate the device's technology and 4 items that evaluate services surrounding the device. It allows patients to express themselves on the criteria that are most important to them. Each item has a score that varies between 0 (not satisfied at all) and 5 (very satisfied). The global score is the average obtained onto the 12 items. Two sub-scores related to the technology and services can also be calculated. They correspond to the average of the 8 first items and to the 4 last items respectively. All scores ranks between 0 and 5, 5 being the highest level of satisfaction. Measurement will be performed at 3 months with 3C60 and at 1 month with NMPK
Secondary SF-36v2™ Health Survey 36-Item Short Form Health Survey (SF-36v2TM) explores 8 dimensions of quality of life through 36 questions: PF= Physical Functioning (10 items), RP= Role Physical (4 items), BP = Bodily Pain (2 items), SF= Social Functioning (2 items), MH= Mental Health (5 items), RE= Role emotional (3 items), VT= Vitality (4 items), GH= General Health (5 items). All of the eight health domain scales contributes with different levels to score two component summary measures: PCS= Physical Component Summary and MCS= Mental Component Summary. All scores are calculated online through scoring software. Domain scales and component summary are ranging from 0 to 100. A high score is considered to be a better outcome, as indicating little or no problem. Measurement will be performed at 3 months with 3C60 and at 1 month with NMPK
Secondary Number of Falls Measurement will be performed at 1 month with both devices